Brief: Veracyte Announces Fourth Quarter And Full-Year 2021 Financial Results
Feb 28 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2021
FINANCIAL
RESULTS
* Q4 LOSS PER SHARE $0.15
* Q4 REVENUE ROSE 95 PERCENT TO $67.3 MILLION
* SEES FY REVENUE UP 18 TO 25 PERCENT
* SEES FY REVENUE $260 MILLION TO $275 MILLION
* Q4 EARNINGS PER SHARE VIEW $-0.15, REVENUE VIEW $61.8
MILLION --
REFINITIV IBES DATA
* FY2022 REVENUE VIEW $268.0 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw5cxg0xa
Further company coverage: VCYT.O
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina